Hostname: page-component-89b8bd64d-z2ts4 Total loading time: 0 Render date: 2026-05-05T14:59:23.975Z Has data issue: false hasContentIssue false

The rapacious ambivalence of VC investment: Venture capital, value capture, and the valorization of crisis

Published online by Cambridge University Press:  16 April 2024

Mark Howard*
Affiliation:
Department of Politics, University of California Santa Cruz, Santa Cruz, CA, USA
Rights & Permissions [Opens in a new window]

Abstract

This article explores venture capital (VC) as a means and process of accumulating future social necessity. It explores the mechanisms of growth that make VC-backed firms distinct. I argue that a distinctive feature of surplus value capture through VC is valorization via socially necessary contracted space-time, a corrective to Marx’s theorization of socially necessary labor time, which appears incomplete in the context of VC. First, extending Marx’s general formula for capital, I develop a general formula for VC, demonstrating how the VC investment upends traditional theories of capitalist accumulation. Second, I argue that VC invests in firms seeking to capture ‘human capital’ resources and uncapitalized market ‘space’ (noncapitalist social logics of exchange) with the aim of achieving ‘product-market fit’. Third, I demonstrate how time and space are contracted under the VC process as a value capture (VC) mechanism relating to future social necessity. VC is, I argue, about accumulating today what we will all need to be consuming tomorrow, just to keep up with social norms. Finally, I explore how the valorization of crisis (VC) demonstrates the accumulation of future social necessity in practice. I conclude with thoughts concerning the possibility of alternatives beyond the overdetermined rapacity of ‘VC’.

Information

Type
Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of the Finance and Society Network
Figure 0

Figure 1. Moderna Therapeutics net loss.Source: Moderna Annual Financial Reports.

Figure 1

Figure 2. The general formula for venture capital.

Figure 2

Figure 3. The general formula for venture capital (portfolio/fund view).

Figure 3

Figure 4. The general formula for venture capital (product-market fit).

Figure 4

Figure 5. The general formula for venture capital (desire basis).

Figure 5

Figure 6. The general formula for venture capital (social necessity).

Figure 6

Figure 7. Contracted time: The voice of exit.

Figure 7

Figure 8. Contracted space: The Silicon Valley Consensus.

Figure 8

Figure 9. The general formula for venture capital (contracted space-time).